Retina

Salvation of ocular tissues and visual acuity are dependent on early diagnosis, investigators emphasised

Highlights from the 2025 Heidelberg Engineering International SPECTRALIS Symposium—And Beyond

New financing will support the company's lead retinitis pigmentosa programme, among other projects

Sandoz will hold exclusive or semi-exclusive marketing rights in several European and Asian countries

An ophthalmologic examination revealed bilateral anterior uveitis, though the patient had no ocular complaints at presentation

João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases

In a press release, the National Institute for Health and Care Excellence announced the first-ever approval for a mitochondrial disease treatment

GLP-1 therapies could impact long-term outcomes in diabetic retinopathy

Enhanced screenings and a unified registry could save vision and lives

The Global RDH12 Alliance unites inherited retinal disease advocacy groups including UK-based Eyes on the Future and the US-based RDH12 Fund for Sight

The IRIS is a cloud-based model that supports artificial intelligence-assisted diabetic retinopathy screening

Exonate initiates a phase 2b trial for EXN407, a groundbreaking eye drop treatment for diabetic retinopathy

Optical coherence tomography may help identify patients at risk of cardiovascular disease before coronary angiography

According to the company, the EMA’s opinion was based on the “totality of evidence comprising a comprehensive analytical, non-clinical and clinical data package”

Rhino-orbital-cerebral mucormycosis, a life-threatening fungal infection, typically occurs in patients with diabetes

Findings from a phase 2 clinical trial support the therapeutic potential of ADX-2191 in patients with retinitis pigmentosa

The platform, developed by University College London and Heidelberg Engineering, demonstrated accuracy and precision in early tests

Researchers at the Korea Advanced Institute of Science and Technology demonstrated the next-generation strategy for sustainable synthesis

Cannabis has been shown to reduce microglial activity, expression of inflammatory cytokines and retinal neurotoxicity

Health Canada approves Aflivu, a biosimilar for retinal diseases, enhancing treatment options and affordability for Canadian patients.

Phil Lai, MD, chief medical officer of Perfuse Therapeutics, said the company's goal is to pioneer disease-modifying treatment that targets an underlying pathology of ischemia

The imaging innovation project is named after the company's co-founder Gerhard Zinser, PhD

In-orbit imaging drives innovation in terrestrial telemedicine, the NASA scientist explained

Investigators obtained data from genome‐wide association studies to examine the effects of instant coffee consumption